Related Experiment Video
Updated: Jan 19, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
RRAS2 knockdown suppresses osteosarcoma progression by inactivating the MEK/ERK signaling pathway
1Department of Orthopaedics, Jingzhou Central Hospital, Jingzhou.
Abstract:
Aberrant function of RRAS2 drives malignant transformation in a various of cancers. However, little information exists on the function of RRAS2 in tumorigenesis of osteosarcoma. In this study, we investigated the effect of RRAS2 on osteosarcoma progression and its underlying mechanism. The gene expression level and prognostic power of RRAS2 in osteosarcoma were first investigated using the data from the Gene Expression Omnibus database. Then RNA interference was performed to silence the expression of RRAS2 in osteosarcoma cells. Quantitative real-time-PCR and western blot were used to examine the gene and protein expressions of RRAS2 in osteosarcoma cells. In-vitro cancer proliferation and migration were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolum bromide solution and wound-healing assays, respectively. We found that RRAS2 was significantly upregulated in osteosarcoma cells and high expression of RRAS2 was associated with a poor prognosis for patients with osteosarcoma. RNA interference decreased the gene and protein expression of RRAS2, reduced in-vitro the proliferation and migration of osteosarcoma cells, and suppressed the activation of the MEK/ERK signaling pathway. RRAS2 as an adverse prognostic factor promoted cell proliferation and migration by activating the MEK/ERK signaling pathway, and may provide new therapeutic value for osteosarcoma.
Insights
Ras-related protein 2 (RRAS2) is upregulated in osteosarcoma, promoting cancer cell proliferation and migration. Silencing RRAS2 inhibits tumor progression and MEK/ERK pathway activation, suggesting RRAS2 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Aberrant RAS homolog and RAS p21 protein (RRAS2) function is implicated in various cancers.
- The role of RRAS2 in osteosarcoma tumorigenesis remains largely unexplored.
Purpose of the Study:
- To investigate the role of RRAS2 in osteosarcoma progression.
- To elucidate the underlying molecular mechanisms of RRAS2 in osteosarcoma.
Main Methods:
- Analysis of RRAS2 gene expression and prognostic value using Gene Expression Omnibus (GEO) database.
- RNA interference (RNAi) to silence RRAS2 expression in osteosarcoma cells.
- Quantitative real-time PCR (qRT-PCR) and Western blot for gene and protein expression analysis.
- In vitro proliferation (MTT assay) and migration (wound-healing assay) assessments.
- Evaluation of MEK/ERK signaling pathway activation.
Main Results:
- RRAS2 was significantly upregulated in osteosarcoma tissues and cell lines.
- High RRAS2 expression correlated with poor patient prognosis.
- RNAi-mediated RRAS2 silencing reduced osteosarcoma cell proliferation and migration.
- RRAS2 silencing suppressed the activation of the MEK/ERK signaling pathway.
Conclusions:
- RRAS2 acts as an adverse prognostic factor in osteosarcoma.
- RRAS2 promotes osteosarcoma cell proliferation and migration via activation of the MEK/ERK pathway.
- Targeting RRAS2 may offer a novel therapeutic strategy for osteosarcoma.
More Related Videos
07:55Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
11:00Photostimulation by Femtosecond Laser Activates Extracellular-signal-regulated Kinase ERK Signaling or Mitochondrial Events in Target Cells
Published on: July 6, 2019
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
X-Inactivation
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
08:40Spatial and Temporal Analysis of Active ERK in the C. elegans Germline